Therapeutic Targeting of Signal Transduction Pathways and Proteins in Breast Cancer Nancy E. HynesWilliam Gullick Introduction 22 July 2006 Pages: 1 - 2
The Role of the Epidermal Growth Factor Receptor in Breast Cancer Samuel K. ChanMark E. HillWilliam J. Gullick OriginalPaper 09 August 2006 Pages: 3 - 11
The ErbB2 Signaling Network as a Target for Breast Cancer Therapy Ali BadacheAnthony Gonçalves OriginalPaper 09 August 2006 Pages: 13 - 25
Inhibitors of Insulin-like Growth Factor Signaling: A Therapeutic Approach for Breast Cancer Deepali SachdevDouglas Yee OriginalPaper 09 August 2006 Pages: 27 - 39
Notch Signaling in Breast Cancer and Tumor Angiogenesis: Cross-Talk and Therapeutic Potentials Wen ShiAdrian L. Harris OriginalPaper 09 August 2006 Pages: 41 - 52
The mTOR Pathway in Breast Cancer Nancy E. HynesAnne Boulay OriginalPaper 09 August 2006 Pages: 53 - 61
Exploiting Our Knowledge of NF-κB Signaling for the Treatment of Mammary Cancer Michael C. HaffnerChiara BerlatoWolfgang Doppler OriginalPaper 10 August 2006 Pages: 63 - 73
The Biological Functions of the Versatile Transcription Factors STAT3 and STAT5 and New Strategies for their Targeted Inhibition Sylvane DesrivièresChristian KunzBernd Groner OriginalPaper 09 August 2006 Pages: 75 - 87
ErbB Receptor Negative Regulatory Mechanisms: Implications in Cancer Colleen SweeneyJamie K. MillerKermit L. Carraway III OriginalPaper 25 July 2006 Pages: 89 - 99
